Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion
{{output}}
Background: Obesity is associated with cardiovascular (CV) risk. Several medications previously used for weight management have been withdrawn or contraindicated in individuals with hypertension due to concerns about adverse CV e... ...
